Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease arthritis, psoriatic
Comorbidity C0033860|psoriasis
Sentences 50
PubMedID- 23990278 The patients are similar to those normally seen by clinicians, and include a male patient with plaque psoriasis and a history of severe psoriatic arthritis who was corticosteroid dependent and in whom other systemic treatments were not effective or were not able to be used.
PubMedID- 26206134 Reliability and validity of the psoriasis symptom inventory in patients with psoriatic arthritis.
PubMedID- 25580230 Objective: we sought to elucidate the pathogenesis of psoriatic diseases by determining the differences in metabolomic profiles among psoriasis patients with or without psoriatic arthritis and healthy controls.
PubMedID- 25071247 It is important, therefore, for dermatologists to be aware of the early symptoms of psoriatic arthritis, particularly in patients with nail psoriasis, in order to avoid progressive joint damage.
PubMedID- 24150746 Prevalence of psoriatic arthritis in psoriasis patients according to newer classification criteria.
PubMedID- 25814713 First case a 52 year man, a known case of psoriasis vulgaris with psoriatic arthropathy of 15 years duration received multiple modalities of therapies without any satisfactory response.
PubMedID- 26019683 Temporomandibular disorders in psoriasis patients with and without psoriatic arthritis: an observational study.
PubMedID- 24763845 Ostraceous and inverse psoriasis with psoriatic arthritis as the presenting features of advanced hiv infection.
PubMedID- 23311587 Comparison of three screening tools to detect psoriatic arthritis in patients with psoriasis (contest study).
PubMedID- 23493653 The estimated prevalence of psoriatic arthritis among patients with psoriasis is 4–42% (typically 7–10%).
PubMedID- 24127271 [65] suggested that ultrasound can help to predict the likelihood of developing psoriatic arthropathy in patients with psoriasis based on sonographically visible but clinically asymptomatic tendon changes.
PubMedID- 23205325 The successful combination of methotrexate and cyclosporine for severe pustular psoriasis associated with psoriatic arthritis has also been reported (grade b evidence) [68, 69].
PubMedID- 22730367 High prevalence of psoriatic arthritis in patients with severe psoriasis with suboptimal performance of screening questionnaires.
PubMedID- 21701797 We report a high prevalence of severe psoriasis among patients with psoriatic arthritis, higher in women and patients with psoriatic nail disease and axial spondyloarthropathy.
PubMedID- 20536647 Cases were psoriasis patients with psoriatic arthritis while controls were psoriasis patients without psoriatic arthritis.
PubMedID- 24839574 We report here the occurrence of articular symptoms related to psoriatic arthritis (psa) in a patient with ms and psoriasis receiving ifn-β.
PubMedID- 21511512 Stratification by age of onset with 30 years as age limit is an effective means of identifying psors1-associated psoriasis in patients with psoriatic arthritis.
PubMedID- 22298266 The study design of the prepare (prevalence of psoriatic arthritis in adults with psoriasis) trial was also presented.
PubMedID- 23110708 Chemerin levels were higher in patients affected by psoriatic arthritis than in patients with psoriasis without arthritis (195.5+/-49.1 vs.
PubMedID- 23007291 Combination therapy of infliximab and granulocyte/monocyte adsorption apheresis for refractory pustular psoriasis with psoriatic arthritis.
PubMedID- 26058346 These results suggest need for screening for psoriatic arthritis in patients with psoriasis to reduce the burden of physical quality of life and screening for early signs of psychiatric illnesses in both these disease populations.
PubMedID- 22035157 Background: moderate/severe psoriasis combined with psoriatic arthritis (psa) impairs health-related quality of life (qol).
PubMedID- 24600238 The pasi index does not specifically include nail psoriasis or the presence of psoriatic arthritis, which may reflect greater disease severity.
PubMedID- 23580094 Therapeutic strategies in psoriasis patients with psoriatic arthritis: focus on new agents.
PubMedID- 23981683 Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in european/north american dermatology clinics.
PubMedID- 24269700 A case-control study was performed, and five tnfsf15 snps (rs3810936, rs6478108, rs6478109, rs7848647, rs7869487) were genotyped in 319 patients with psoriasis, 105 of whom also have psoriatic arthritis, and in 200 healthy individuals.
PubMedID- 22941766 Conclusions: psoriasis with concomitant psoriatic arthritis is associated with an increased risk of incident cd.
PubMedID- 24128349 One hundred severe psoriasis patients without psoriatic arthritis or previous cardiovascular disease were evaluated and it was found that more than half of the patients were reclassified to a higher cardiovascular risk category with important clinical implications on the correct management of their cardiovascular risk factors and primary prevention of cardiovascular disease, as a considerable proportion of patients with hypertension, hypercholesterolemia and coronary heart disease equivalent risk were not being correctly managed.
PubMedID- 26025585 Up to one third of patients with psoriasis are diagnosed with psoriatic arthritis (psa).
PubMedID- 26138406 Background: moderate to severe plaque psoriasis (with or without psoriatic arthritis) places significant burden on patients' lives.
PubMedID- 25726029 Patients with 2 or more medical claims with a diagnosis of psoriasis (excluding psoriatic arthritis) who were enrolled in large employer-sponsored health plans (including a pharmacy benefit) in the united states from january 2007 to march 2012 were identified and extracted from the marketscan commercial encounters database.
PubMedID- 24283931 Cardiometabolic, clinical and quality-of-life (qol) measures were assessed before and after etanercept treatment in patients who had moderate-to-severe plaque psoriasis with and without psoriatic arthritis (psa) in the pristine trial.
PubMedID- 25362715 Safety and efficacy of therapies for skin symptoms of psoriasis in patients with psoriatic arthritis: a systematic review.
PubMedID- 26026773 Nail psoriasis as a predictor of the development of psoriatic arthritis.
PubMedID- 21349114 Background: the prevalence and clinical characteristics of psoriatic arthritis (psa) in patients with psoriasis vary widely in different countries and studies on chinese population are rarely reported.
PubMedID- 24861696 Background: etanercept (etn) 50 mg once weekly (qw) or 50 mg twice weekly (biw) for 12 weeks, followed by 50 mg qw in all subjects to week 24 improved psoriasis in patients with concomitant psoriatic arthritis in the presta trial.
PubMedID- 21716541 Palmer-plantar), psoriasis with concomitant psoriatic arthritis, pustular, erythrodermic and guttate variants and psoriasis unresponsive to topical medications in which significant physical, social or emotional impairments are involved.
PubMedID- 25303478 Objective: to compare the prevalence of comorbidities, health care utilization, and costs between moderate-to-severe psoriasis (pso) patients with comorbid psoriatic arthritis (psa) and matched controls.
PubMedID- 19807825 Patients/methods: seven patients suffering from severe plaque-type psoriasis and 14 with psoriatic arthritis and cutaneous psoriasis with concomitant nail involvement were enrolled into the study.
PubMedID- 23637091 Among kpnc adults, the point prevalence of psoriasis, with or without psoriatic arthritis, was 939 (95% ci, 765-1142) per 100 000, and the overall prevalence of psoriatic arthritis, with or without psoriasis, was 68 (95% ci, 54-84) per 100 000.
PubMedID- 24249911 Here, we present a case of psoriasis with psoriatic arthritis on long- term methotrexate developing acral lentiginous melanoma, which was completely treated with wide excision and chemotherapy.
PubMedID- 24260178 Cutaneous psoriasis frequently occurs with psoriatic arthritis, and a number of psoriasis co-morbidities have been recognized, including obesity [2], metabolic syndrome [3], hypertension [4], and increased use of anti-depressants [5].
PubMedID- 24803232 Prevalence of psoriatic arthritis in psoriasis patients according to newer classification criteria.
PubMedID- 24985559 psoriatic arthritis (psa) is associated with psoriasis with a prevalence varying from 5.94% to 23.9%.
PubMedID- 26242857 Paradoxical psoriatic arthritis in a patient with psoriasis treated with ustekinumab.
PubMedID- 24882864 The criteria are particularly intended to aid non-rheumatologists, e.g., dermatologists, who need assistance identifying psoriatic arthritis in patients with psoriasis, but may be useful to all clinicians in properly diagnosing rheumatologic conditions.
PubMedID- 20461114 The prevalence of psoriatic arthritis among patients with psoriasis has varied from 6% to 42% [55].
PubMedID- 24974240 Comparative performance of psoriatic arthritis screening tools in patients with psoriasis in european/north american dermatology clinics.
PubMedID- 22161801 Methods: in this retrospective cohort study, we utilized claims data from the national health insurance research database of taiwan to identify 179,200 subjects who had received a diagnosis of psoriasis, with or without psoriatic arthritis, on at least 3 visits.
PubMedID- 25834350 Methods: we genotyped 130 patients with psoriasis (26 of whom also had psoriatic arthritis) and 259 controls; rs1800629 and rs3212227, and rs2430561, by real-time pcr assay.

Page: 1